Nephrocare Health Services Limited

Nephrocare Health Services Limited

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement. This agreement facilitates the acquisition of identified assets relating to a dialysis center located in Ipil, Zamboanga Sibugay, Philippines. The total consideration for this acquisition is PhP 80,640,000. This move signifies the company's expansion of its healthcare services in the Philippines market.

Nephrocare Health Services Limited

Nephrocare Health Services' board approved the Employee Stock Option Scheme 2026, enabling the grant of up to 2,006,814 options, representing approximately 2% of its paid-up equity share capital, subject to shareholder and regulatory approvals. Concurrently, the company approved providing collateral/security support of up to INR 70 Crore to its overseas step-down wholly-owned subsidiary in Saudi Arabia. This support aims to enable the subsidiary to avail credit facilities, reflecting a revised funding and operating structure for its Saudi operations and facilitating international growth.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has announced the closure of its trading window for designated persons and their immediate relatives. Effective June 22, 2026, this closure adheres to SEBI (Prohibition of Insider Trading) Regulations, 2015. The reason cited is the existence of Unpublished Price Sensitive Information (UPSI), specifically regarding the unaudited financial results for the quarter ending June 30, 2026. The trading window will remain closed until 48 hours after these financial results are publicly declared, preventing insiders from trading on confidential information.

Nephrocare Health Services Limited

Nephrocare Health Services Limited announced a disclosure from its promoter, Edoras Investment Holdings Pte. Ltd., under SEBI Takeover Regulations 31(4). Edoras Investment Holdings confirmed that no new encumbrances were created on its shares in Nephrocare Health Services during the financial year ended March 31, 2026. This annual declaration assures stakeholders that no additional shares were pledged or used as collateral by the promoter during the period. For investors, this indicates stability in the promoter's shareholding, mitigating concerns about potential selling pressure arising from new pledged shares.